Header Logo

Connection

JAMUNARANI VEERARAGHAVAN to Heterografts

Back to Details
This is a "connection" page, showing publications JAMUNARANI VEERARAGHAVAN has written about Heterografts.
JAMUNARANI VEERARAGHAVAN
Connection Strength
0.034
Heterografts
  1. The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. Br J Cancer. 2019 02; 120(3):331-339.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.